Logo-apb

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308 
pISSN: 2228-5881 

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Powered by
Adv Pharm Bull. 2024;14(3): 604-612. doi: 10.34172/apb.2024.055
PMID: 39494258        PMCID: PMC11530885

Mini Review

Cytobiological Alterations Induced by Celecoxib as an Anticancer Agent for Breast and Metastatic Breast Cancer

Maher Monir. Akl 1 * ORCID, Amr Ahmed 2 ORCID

Cited by CrossRef: 0

1- Li X, Liu S, Wang R, Wang X. Upconversion mesoporous silica nanoparticles co-delivering celecoxib and rose bengal enable multimodal immunogenic and anti-angiogenic therapy for spinal metastasis of non-small cell lung cancer. Oncogene. 2026;45(9):823 [Crossref]
2- Yang Y, Tian C, An X, Fan B, Zha D. Aspirin in Audiology: A Dual-Edged Sword in Hearing Loss and Its Nanotechnology-Driven Future. DDDT. 2026;Volume 20:1 [Crossref]
3- Huang W, Yan Z, Wang Y, Chen Z, Yang X. Uncovering celecoxib’s anti-breast cancer mechanisms through network pharmacology, molecular docking, and dynamics. Letters in Drug Design & Discovery. 2025;22(10):100164 [Crossref]
4- Xu H, Zhang R, Wang D, Jiang Y, Feng J, Zhang H. Repurposing COX-2 Inhibitors for Cancer Therapy: Advances in Nanomedicine Delivery. Chem Res Chin Univ. 2026;42(2):557 [Crossref]
5- Bai C, Xu X, Zhang J, Li X, Zhang T. A Rapid and Sensitive Supercritical Fluid Chromatography–Tandem Mass Spectrometry Method for the Analysis of Celecoxib in Beagle Plasma: Application to Pharmacokinetic Studies. Separation Science Plus. 2025;8(4) [Crossref]
6- Turlej E, Domaradzka A, Koksharov R, Gizak A. Immune-Centered Cross-Talk Between Cancer Cells and the Tumor Microenvironment—Implications for Therapy. Cancers. 2026;18(3):344 [Crossref]
7- Si S, Liu J, Li Z, Wang P, Ma Y. Elucidating the potential mechanism of short-chain chlorinated paraffins in breast cancer via computational prediction integrating network toxicology and molecular docking. Sci Rep. 2026;16(1) [Crossref]
8- Abdel-Aziz A, El-Azab A, Brogi S, Ayyad R, Al-Suwaidan I, Hefnawy M. Antitumor Activity and Multi-Target Mechanism of Phenolic Schiff Bases Bearing Methanesulfonamide Fragments: Cell Cycle Analysis and a Molecular Modeling Study. IJMS. 2024;25(24):13621 [Crossref]
9- Shi P, Xu J, Cui H. Targeting oxygenases could be a viable anti-metastatic approach in cancer therapy. International Journal of Biological Macromolecules. 2025;310:143375 [Crossref]
10- Bakrim S, Fessikh M, Elhrech H, Omari N, Amanullah M, Ming L, Moshawih S, Bouyahya A. Targeting inflammation in cancer therapy: from mechanistic insights to emerging therapeutic approaches. J Transl Med. 2025;23(1) [Crossref]
11- Review on the latest developments in detection and treatment of breast cancer. JCP. 2025;9(2):113 [Crossref]